The filing attributes the increase in net loss of USD 1,193 thousand mainly to a USD 1,427 thousand favorable change in theFair Valueof derivativeWarrantliabilities in the prior-year quarter, with no such activity this quarter because the applicable warrants have expired. It also cites an …
Chief Financial Officer Lara Weber saidResearch and Developmentexpenses were USD 12.5 million, against USD 17.5 million in the third quarter of 2025. She attributed the USD 5 million decrease primarily to reduced spending on the Revita and Rejuva programs and lower personnel-related expenses. Selling, …
The company said it generated revenue primarily through RNK Health, which provides non-clinical services to support patient care, of USD 1,958,620. It also generated USD 855,907 from subscription services from its Art-Gen.ai, unGPT.ai and Bible.ai applications. In the third quarter of 2025, revenue was …
Chief Executive Officer John Serafini said growth on the international side of theBusinesscontinues to gain traction, with international revenue increasing 76% year over year to USD 23.3 million.
Chief Executive Officer Richard Hermanns said the company has reportedGAAPprofitability in each quarter since the third quarter of 2024 and has never reported a loss on a non-GAAP basis. He also said weekly system-wide sales have been up double digits year over year for …
Revenue was USD 72.9 million, against USD 46.3 million. For the nine months, revenue was USD 189.5 million, against USD 126.9 million. Cost of revenue was USD 11.9 million, against USD 10.9 million, andGross Profitwas USD 60.9 million, against USD 35.4 million. Gross profit …
Adjusted gross profit increased 143% quarter over quarter to USD 2.80 million, from USD 1.15 million in the second quarter. The figure was above the USD 2.0 million to USD 2.5 million range the company guided to on September 8, 2026. From the third …
Revenue decreased USD 275 thousand, or 5%, to USD 5,739 thousand. The filing attributes the decrease primarily to lower transaction volumes and lower non-recurring engineering revenue, which is included in other revenue. SaaS revenue decreased 3% to USD 5,721 thousand, against USD 5,868 thousand, …
Manufacturing and clinicalSupplycosts for IMNN-001 supporting the OVATION and MRD programs were USD 0.8 million in the quarter, against USD 0.9 million. The filing attributes the decrease mainly to efficiency in advancing OVATION-3.
Chief Financial Officer Joseph Spain said revenue growth was driven by SaaS and storage and retrieval revenue. SaaS revenue increased 5% to USD 1.7 million, driven primarily by new payables automation and budget tool customers as well as price increases. Software maintenance revenue decreased …